tirzepatide serotonin syndrome What are the considerations for using (a glucagon-like peptide-1 (GLP-1) receptor agonist) with fluvoxamine (a selective reuptake inhibitor (SSRI)) in a patient with type 2 diabetes and depression or anxiety? The Serotonin Syndrome | New
Description
Individuals should embrace a holistic approach, considering factors such as mental health, long-term lifestyle changes, and a supportive healthcare team
9 Serotonin reuptake inhibitors stop serotonin from being transported back to the presynaptic terminal to be degraded
2021 May;39(2):615-630
In the SURMOUNT-1 body composition analysis, the proportion of weight lost was 74% fat mass and 26% lean mass in the tirzepatide group
Severe stomach problems may occur, and patients should notify their healthcare provider if such issues arise
Watermarks, QR code used for identification purposes only
